Prostate cancer is the most commonly diagnosed form of cancer in Australia with 1 in 5 men at risk of developing prostate cancer in their lifetime.
In 2012 more than 20,060 new cases of prostate cancer were diagnosed in Australia and more than 3,110 men died from the disease. Each year prostate cancer claims more men’s lives in this country than breast cancer does in women.
Australian Prostate Cancer (APC) was established to assist with the funding of vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.
APC funds clinical and laboratory based research conducted at the Basil Hetzel Institute for Translational Health Research and The Queen Elizabeth Hospital in South Australia.
Australian Prostate Cancer is part of The Hospital Research Foundation Group.
For every $1 you donate, we provide over $4 in grants to lifesaving prostate cancer research. This is because we are part of The Hospital Research Foundation (THRF) Group. Our administration costs are covered by THRF’s commercial business activities (such as its lottery program), which also boosts our funds to research and patient care each year. You can feel proud knowing your donation makes an even bigger impact to the health and wellbeing of your community.
The audited financial statements of The Hospital Research Foundation can be viewed at
About our logo
Much like the pink ribbon is synonymous with raising awareness about breast cancer, the blue ribbon is most commonly associated with prostate cancer awareness.
To symbolise our commitment to reduce the impact of prostate cancer on Australian men through vital advances in medical research, the APC logo features a blue jigsaw inspired ribbon. The jigsaw pieces represent what we already know about the disease while the missing piece reflects the knowledge we still need to acquire to eradicate the disease.